MedPath

Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial

Phase 2
Completed
Conditions
Diarrhea-predominant Irritable Bowel Syndrome
Functional Diarrhea
Interventions
Other: acupuncture
Other: acupuncture group2
Other: acupuncture group3
Drug: Loperamide
Registration Number
NCT01350570
Lead Sponsor
Chengdu University of Traditional Chinese Medicine
Brief Summary

This trial is to assess the effectiveness of three types of acupuncture for patients with functional diarrhea comparing to a positive drug control.

Detailed Description

Outcome measurements:

The frequency of bowel movement; The bristol stool scale; SF-36 evaluation

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
449
Inclusion Criteria
  1. Diagnosed as diarrhoea-predominant irritable bowel syndrome according to Rome III criteria;
  2. Age between 18 and 65 years old;
  3. Did not take any medicine for bowel symptoms and attend other clinical research;
  4. Have inform consent signed.
Read More
Exclusion Criteria
  1. Diarrhea caused by diseases such as infection, etc.
  2. Patients can't express himself clearly or with mental diseases;
  3. Tumor and other infectious diseases;
  4. With other serious diseases of Cardiovascular, liver, kidney, digestive or blood system; Pregnant women or planned to be pregnant.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
acupuncture group 1acupunctureAcupoints ST25 and BL25 will be used in the group. ST25 locate at the abdomen, while BL25 locate at the back.
acupuncture group 2acupuncture group2Acupoints LI11 and ST37 will be used in this group. LI11 is located at upper limb while ST37 is located at the lower limb.
acupuncture group 3acupuncture group3All acupoints used in acupuncture group1 and acupuncture group2 will be used in this group.
LoperamideLoperamideLoperamide will be used as an active comparator to the acupuncture groups.
Primary Outcome Measures
NameTimeMethod
Average weekly stool frequency4th week after inclusion

Average weekly stool frequency, change from baseline in 4 weeks

Secondary Outcome Measures
NameTimeMethod
Assessment score of Bristol stool scale4th and 8th week after inclusion

Bristol stool scale was designed to classify the human stool into 7 categories.

The seven types of stool are:

Type 1: Separate hard lumps, like nuts (hard to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft Type 5: Soft blobs with clear cut edges (passed easily) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces. Entirely liquid

Assessment score of SF-36 scale4th and 8th after inclusion

The Short Form (36) Health Survey (SF-36) is a survey of patient health. The SF-36 is commonly used in health economics as a variable in the quality-adjusted life year calculation to determine the cost-effectiveness of a health treatment. The chinese version of SF-36 was validated and has been widely used in acupuncture studies.

Number of patients with adverse events after treatment4th week after inclusion

Number of patients with adverse events after treatment will be recorded and compared among three groups.

Trial Locations

Locations (1)

First affiliated hospital of Chengdu university of TCM

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath